Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing.
Alice C RyanJane Ellen CarlandRobert C McLeayCindy LauDeborah J E MarriottRichard Osborne DaySophie Lena StockerPublished in: British journal of clinical pharmacology (2020)
Amikacin dosing and TDM practice was suboptimal compared with guidelines. The model implemented by DoseMeRx® is satisfactory to guide amikacin dosing.